Bill L. Robbins

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

BioClinica, Inc. engages in the provision of integrated and technology-enhanced clinical trial management services. It offers research network, eclinical solutions, randomization and trial supply management, medical imaging, and cardiac safety. The company was founded in 1990 and is headquartered in Princeton, NJ.

ORFID Corporation is an organic electronics company with a unique technology that will enable the manufacture of new products such as light-weight and flexible displays, smart labels and intelligent packaging. Electronic products made with organic components will be dramatically less costly to manufacture and more versatile than today's silicon-based products. ORFID is developing a new organic transistor, the Vertical Organic Field Effect Transistor (VOFET), to replace the conventional silicon semiconductor transistor technology currently used to manufacture products such as flat panel displays and radio frequency identification tags (RFIDs). The Company's initial focus is to enable the development of fully organic displays that are thin, flexible, and inexpensive to manufacture. Conventional organic transistor technologies are woefully inadequate for use in the manufacture of organic light-emitting diode (OLED) displays. Other organic transistors do not have the current-carrying capacity required to power OLEDs. With its unique device architecture, ORFID's VOFET is a potentially disruptive technology that can provide one thousand times the current of competing organic transistors at significantly lower operating voltages. In addition, the VOFET's unique architecture lends itself to simpler manufacture. The VOFET's superior current-carrying capacity and its novel architecture give ORFID a distinct technical advantage for exploiting organic transistors to manufacture OLED displays. ORFID will also leverage its core capabilities to develop and commercialize organic RFID technologies. Organic electronics are expected to enable low-cost, high volume RFID tagging of items, 10 trillion a year by some estimates. The inherent printability of organic electronics means that the production of organic devices may one day be combined with conventional printing and packaging processes, allowing the fabrication of products such as smart packages, papers and textiles in the same pass. ORFID's organic electronic technologies and patent portfolio allow it to decisively enter this market place in the area of low cost printable electronics for the manufacture of RFID tags.

Grey Global Group LLC operates as a marketing communication agency. The company was founded on August 1, 1917 and is headquartered in New York, NY.

Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA.

Convergent Ventures LLC is a venture capital firm located in Los Angeles. The firm is headquartered in California.